GlassScriptPhysician profile
Lance J Wehrly
NPI 1699966549
$3,745.34
in general payments reported to CMS, 2019-2025
13 companies · $988 in 2025
The $988 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $213 · 2021: $210 · 2022: $310 · 2023: $695 · 2024: $664 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662 · Consulting Fee: $500 · Travel and Lodging: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.39 |
| Consulting Fee | $500.00 |
| Travel and Lodging | $184.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,486.91 | 2019-2025 | Na, Tfn-Advance, Va-Lcp |
| Stryker Corporation | $1,056.68 | 2019-2025 | Mako, Inspace |
| Linvatec Corporation | $613.47 | 2024-2025 | Biobrace 23mm |
| Horizon Therapeutics Plc | $276.76 | 2019-2022 | |
| Boston Scientific Corporation | $104.16 | 2019 | |
| Vericel Corporation | $56.74 | 2021-2022 | |
| Bioventus LLC | $37.49 | 2025 | Xcell |
| Pacira Pharmaceuticals Incorporated | $28.01 | 2021-2022 | |
| Medical Device Business Services, INC. | $19.86 | 2024 | N/A |
| Medtronic, INC. | $18.38 | 2023 | Linq II |
| Sonex Health, INC. | $16.64 | 2024 | Sx-One Microknife |
| Abbvie INC. | $16.05 | 2024 | |
| Davol INC. | $14.19 | 2024 | Channel Drain |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Wehrly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.